Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Receivables - Other (2017 - 2021)

Historic Receivables - Other for Mimedx (MDXG) over the last 5 years, with Q2 2021 value amounting to $400000.0.

  • Mimedx's Receivables - Other changed N/A to $400000.0 in Q2 2021 from the same period last year, while for Jun 2021 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $200000.0 for FY2020, which is 8461.54% down from last year.
  • As of Q2 2021, Mimedx's Receivables - Other stood at $400000.0.
  • Over the past 5 years, Mimedx's Receivables - Other peaked at $5.9 million during Q4 2017, and registered a low of $200000.0 during Q4 2020.
  • Over the past 5 years, Mimedx's median Receivables - Other value was $1.0 million (recorded in 2019), while the average stood at $2.0 million.
  • As far as peak fluctuations go, Mimedx's Receivables - Other crashed by 8461.54% in 2020, and later soared by 1666.67% in 2021.
  • Over the past 5 years, Mimedx's Receivables - Other (Quarter) stood at $5.9 million in 2017, then dropped by 27.12% to $4.3 million in 2018, then plummeted by 69.77% to $1.3 million in 2019, then tumbled by 84.62% to $200000.0 in 2020, then surged by 100.0% to $400000.0 in 2021.
  • Its last three reported values are $400000.0 in Q2 2021, $700000.0 for Q1 2021, and $200000.0 during Q4 2020.